We report the synthesis and characterizations of a new FeSe-based compound CsFeSe, which is closely related to alkali intercalated FeSe superconductors while exhibits distinct features. It does not undergo phase separation and antiferromagnetic transition. Powder neutron diffractions, electron microscopy and high-angle annular-dark-field images confirm that CsFeSe possesses an ordered Cs arrangement as √2 × √2 superstructure, evidencing a B-centered orthorhombic lattice with a space group of Bmmm. The temperature-dependent powder neutron diffractions indicate no structural and magnetic transition from 320 to 5 K. In contrast to the symmetry-breaking in FeSe, this phase naturally possesses the orthorhombic symmetry even at room temperature. DFT calculations and transport measurements reveal a novel Fermi surface geometry with two electron-like sheets centered on Γ point and intermediate density of states at the Fermi level comparing with the value of FeSe and the superconducting A FeSe.
We report here the first layered iron oxychalcogenide Ca2O3Fe2.6S2 that contains both planar [Ca2FeO2](2+) and [Fe2OS2](2-) layers with the shortest Fe-Fe bond length. This compound is a narrow band gap (~0.073 eV) Mott insulator. The observed antiferromagnetic (AFM) transition at 77 K is due to the ordered Fe vacancies, which can be suppressed by partial substitution of Se for S. We show that the vacancy-free phase Ca2O3Fe3S2 may become a metal with moderate electron correlation comparable to the parent compound LaOFeAs of corresponding superconductors. Our results imply that iron oxychalcogenide can be converted from an AFM Mott insulator into a bad metal like iron pnictides through Fe-Fe bond length shrinking.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.